

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.10145660 |
| 2 | central nervous system myelination (GO:0022010) | 7.10145660 |
| 3 | protoporphyrinogen IX metabolic process (GO:0046501) | 6.98438137 |
| 4 | gas transport (GO:0015669) | 5.48126961 |
| 5 | oxygen transport (GO:0015671) | 5.31058613 |
| 6 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.24233941 |
| 7 | fatty acid elongation (GO:0030497) | 5.01250228 |
| 8 | hemoglobin metabolic process (GO:0020027) | 4.95099296 |
| 9 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.91145827 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.80385308 |
| 11 | ensheathment of neurons (GO:0007272) | 4.72745434 |
| 12 | axon ensheathment (GO:0008366) | 4.72745434 |
| 13 | myelination (GO:0042552) | 4.69871992 |
| 14 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.61876386 |
| 15 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.54465871 |
| 16 | myofibril assembly (GO:0030239) | 4.37232510 |
| 17 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.33075986 |
| 18 | cardiac muscle hypertrophy (GO:0003300) | 4.25863834 |
| 19 | cardiac myofibril assembly (GO:0055003) | 4.24829486 |
| 20 | negative regulation of inclusion body assembly (GO:0090084) | 4.21830064 |
| 21 | tetrapyrrole biosynthetic process (GO:0033014) | 4.19033551 |
| 22 | striated muscle hypertrophy (GO:0014897) | 4.14985547 |
| 23 | creatine metabolic process (GO:0006600) | 4.11845763 |
| 24 | axonemal dynein complex assembly (GO:0070286) | 4.04662863 |
| 25 | regulation of cardioblast differentiation (GO:0051890) | 4.04208971 |
| 26 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.99780267 |
| 27 | cell communication by electrical coupling (GO:0010644) | 3.96525298 |
| 28 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.94853097 |
| 29 | iron ion import (GO:0097286) | 3.90982465 |
| 30 | cardiac muscle contraction (GO:0060048) | 3.84021858 |
| 31 | porphyrin-containing compound metabolic process (GO:0006778) | 3.83631810 |
| 32 | sarcomere organization (GO:0045214) | 3.82886288 |
| 33 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.79641395 |
| 34 | cilium movement (GO:0003341) | 3.76763504 |
| 35 | erythrocyte development (GO:0048821) | 3.76016730 |
| 36 | L-phenylalanine catabolic process (GO:0006559) | 3.75540874 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.75540874 |
| 38 | relaxation of cardiac muscle (GO:0055119) | 3.71161511 |
| 39 | asymmetric protein localization (GO:0008105) | 3.70932735 |
| 40 | erythrocyte maturation (GO:0043249) | 3.69120868 |
| 41 | myelin maintenance (GO:0043217) | 3.66808739 |
| 42 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.66023060 |
| 43 | regulation of relaxation of muscle (GO:1901077) | 3.63307360 |
| 44 | regulation of actin filament-based movement (GO:1903115) | 3.59863301 |
| 45 | sperm motility (GO:0030317) | 3.59788135 |
| 46 | cell communication involved in cardiac conduction (GO:0086065) | 3.58108396 |
| 47 | muscle hypertrophy (GO:0014896) | 3.57866341 |
| 48 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.56356673 |
| 49 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.55594615 |
| 50 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.51754863 |
| 51 | apical protein localization (GO:0045176) | 3.44035088 |
| 52 | definitive hemopoiesis (GO:0060216) | 3.42429055 |
| 53 | epithelial cilium movement (GO:0003351) | 3.42399840 |
| 54 | cysteine metabolic process (GO:0006534) | 3.39609534 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.39417923 |
| 56 | L-phenylalanine metabolic process (GO:0006558) | 3.39417923 |
| 57 | aspartate family amino acid catabolic process (GO:0009068) | 3.39273269 |
| 58 | establishment of mitochondrion localization (GO:0051654) | 3.33441131 |
| 59 | actin-myosin filament sliding (GO:0033275) | 3.32466912 |
| 60 | muscle filament sliding (GO:0030049) | 3.32466912 |
| 61 | regulation of the force of heart contraction (GO:0002026) | 3.31346634 |
| 62 | acrosome reaction (GO:0007340) | 3.30900830 |
| 63 | cholesterol biosynthetic process (GO:0006695) | 3.27406554 |
| 64 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.27068488 |
| 65 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.26660530 |
| 66 | response to methylmercury (GO:0051597) | 3.25394261 |
| 67 | cardiac muscle cell development (GO:0055013) | 3.23320027 |
| 68 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.20612754 |
| 69 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.18482392 |
| 70 | muscle hypertrophy in response to stress (GO:0003299) | 3.18482392 |
| 71 | cardiac muscle adaptation (GO:0014887) | 3.18482392 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 3.18231684 |
| 73 | one-carbon compound transport (GO:0019755) | 3.17064646 |
| 74 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.17062158 |
| 75 | virion attachment to host cell (GO:0019062) | 3.15383260 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 3.15383260 |
| 77 | response to mercury ion (GO:0046689) | 3.15143984 |
| 78 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.14470655 |
| 79 | thioester biosynthetic process (GO:0035384) | 3.13046396 |
| 80 | acyl-CoA biosynthetic process (GO:0071616) | 3.13046396 |
| 81 | heme biosynthetic process (GO:0006783) | 3.13019209 |
| 82 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.11452791 |
| 83 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.10124938 |
| 84 | desmosome organization (GO:0002934) | 3.09060710 |
| 85 | actomyosin structure organization (GO:0031032) | 3.08280298 |
| 86 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.07162808 |
| 87 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.06825646 |
| 88 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.06624166 |
| 89 | astrocyte development (GO:0014002) | 3.05071086 |
| 90 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.04986645 |
| 91 | glycerophospholipid catabolic process (GO:0046475) | 3.02703817 |
| 92 | acetyl-CoA metabolic process (GO:0006084) | 3.02050346 |
| 93 | regulation of response to osmotic stress (GO:0047484) | 3.01853727 |
| 94 | cardiac cell development (GO:0055006) | 2.99231073 |
| 95 | carnitine transport (GO:0015879) | 2.98164290 |
| 96 | amino-acid betaine transport (GO:0015838) | 2.98164290 |
| 97 | actin-mediated cell contraction (GO:0070252) | 2.98018330 |
| 98 | sperm capacitation (GO:0048240) | 2.96418620 |
| 99 | cardiac conduction (GO:0061337) | 2.93382205 |
| 100 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.91990458 |
| 101 | striated muscle contraction (GO:0006941) | 2.91959037 |
| 102 | heme transport (GO:0015886) | 2.91951298 |
| 103 | muscle tissue morphogenesis (GO:0060415) | 2.91681983 |
| 104 | regulation of cell communication by electrical coupling (GO:0010649) | 2.91422797 |
| 105 | protein localization to endosome (GO:0036010) | 2.89809459 |
| 106 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.88340038 |
| 107 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.87660155 |
| 108 | short-chain fatty acid metabolic process (GO:0046459) | 2.87636616 |
| 109 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.87218125 |
| 110 | regulation of inclusion body assembly (GO:0090083) | 2.85700410 |
| 111 | photoreceptor cell differentiation (GO:0046530) | 2.85130314 |
| 112 | eye photoreceptor cell differentiation (GO:0001754) | 2.85130314 |
| 113 | triglyceride biosynthetic process (GO:0019432) | 2.83555923 |
| 114 | sterol biosynthetic process (GO:0016126) | 2.83522886 |
| 115 | cardiac muscle cell action potential (GO:0086001) | 2.80607660 |
| 116 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.80359180 |
| 117 | acrosome assembly (GO:0001675) | 2.78546265 |
| 118 | very long-chain fatty acid metabolic process (GO:0000038) | 2.78407463 |
| 119 | plasma membrane fusion (GO:0045026) | 2.78342912 |
| 120 | adult heart development (GO:0007512) | 2.77922096 |
| 121 | carnitine transmembrane transport (GO:1902603) | 2.77437276 |
| 122 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.77350723 |
| 123 | embryonic process involved in female pregnancy (GO:0060136) | 2.76464135 |
| 124 | neurotransmitter catabolic process (GO:0042135) | 2.76298589 |
| 125 | positive regulation of p38MAPK cascade (GO:1900745) | 2.75528237 |
| 126 | acylglycerol biosynthetic process (GO:0046463) | 2.75070118 |
| 127 | neutral lipid biosynthetic process (GO:0046460) | 2.75070118 |
| 128 | ketone body metabolic process (GO:1902224) | 2.74893469 |
| 129 | drug transmembrane transport (GO:0006855) | 2.74031087 |
| 130 | multicellular organism reproduction (GO:0032504) | 2.71729859 |
| 131 | import into cell (GO:0098657) | 2.71160615 |
| 132 | oligodendrocyte differentiation (GO:0048709) | 2.68203542 |
| 133 | Leydig cell differentiation (GO:0033327) | 2.66041932 |
| 134 | spermatid development (GO:0007286) | 2.64047049 |
| 135 | glyoxylate metabolic process (GO:0046487) | 2.63281605 |
| 136 | interkinetic nuclear migration (GO:0022027) | 2.62555730 |
| 137 | relaxation of muscle (GO:0090075) | 2.61935812 |
| 138 | positive regulation of gluconeogenesis (GO:0045722) | 2.61415870 |
| 139 | sodium ion export (GO:0071436) | 2.61378150 |
| 140 | quaternary ammonium group transport (GO:0015697) | 2.60532724 |
| 141 | negative regulation of hormone metabolic process (GO:0032351) | 2.60486947 |
| 142 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.59764843 |
| 143 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.59704832 |
| 144 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.59612309 |
| 145 | regulation of collateral sprouting (GO:0048670) | 2.57640530 |
| 146 | polyol transport (GO:0015791) | 2.56280933 |
| 147 | adhesion of symbiont to host (GO:0044406) | 2.55761236 |
| 148 | ventricular system development (GO:0021591) | 2.55581076 |
| 149 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.54600736 |
| 150 | glutathione derivative biosynthetic process (GO:1901687) | 2.54364444 |
| 151 | glutathione derivative metabolic process (GO:1901685) | 2.54364444 |
| 152 | embryonic heart tube development (GO:0035050) | 2.54257402 |
| 153 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.53677768 |
| 154 | negative regulation of neurotransmitter transport (GO:0051589) | 2.52787139 |
| 155 | substantia nigra development (GO:0021762) | 2.52341226 |
| 156 | negative regulation of protein localization to cell surface (GO:2000009) | 2.52143636 |
| 157 | endocardial cushion development (GO:0003197) | 2.51958971 |
| 158 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.51930246 |
| 159 | acyl-CoA metabolic process (GO:0006637) | 2.51902818 |
| 160 | thioester metabolic process (GO:0035383) | 2.51902818 |
| 161 | regulation of lipoprotein metabolic process (GO:0050746) | 2.51761859 |
| 162 | response to lead ion (GO:0010288) | 2.51213152 |
| 163 | atrioventricular valve morphogenesis (GO:0003181) | 2.51020869 |
| 164 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.50389822 |
| 165 | regulation of striated muscle contraction (GO:0006942) | 2.50286953 |
| 166 | iron coordination entity transport (GO:1901678) | 2.50158490 |
| 167 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.47969778 |
| 168 | myelination in peripheral nervous system (GO:0022011) | 2.47891695 |
| 169 | peripheral nervous system axon ensheathment (GO:0032292) | 2.47891695 |
| 170 | lysine metabolic process (GO:0006553) | 2.47653326 |
| 171 | lysine catabolic process (GO:0006554) | 2.47653326 |
| 172 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.47516515 |
| 173 | organic cation transport (GO:0015695) | 2.47390668 |
| 174 | membrane tubulation (GO:0097320) | 2.46489666 |
| 175 | actin filament capping (GO:0051693) | 2.46293042 |
| 176 | aromatic amino acid family catabolic process (GO:0009074) | 2.45821937 |
| 177 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.45790866 |
| 178 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.45593830 |
| 179 | axoneme assembly (GO:0035082) | 2.45311124 |
| 180 | glutathione biosynthetic process (GO:0006750) | 2.45272942 |
| 181 | carnitine shuttle (GO:0006853) | 2.42508434 |
| 182 | adrenergic receptor signaling pathway (GO:0071875) | 2.42284701 |
| 183 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.41150977 |
| 184 | alditol metabolic process (GO:0019400) | 2.40416965 |
| 185 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.40194997 |
| 186 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.39968193 |
| 187 | fatty acid transmembrane transport (GO:1902001) | 2.39961889 |
| 188 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.39771925 |
| 189 | regulation of heart rate (GO:0002027) | 2.39734574 |
| 190 | fatty acid beta-oxidation (GO:0006635) | 2.39634976 |
| 191 | regulation of cardiac muscle contraction (GO:0055117) | 2.39371713 |
| 192 | detection of calcium ion (GO:0005513) | 2.38408774 |
| 193 | myeloid cell development (GO:0061515) | 2.36509407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 5.49015499 |
| 2 | GATA1_19941826_ChIP-Seq_K562_Human | 4.19194555 |
| 3 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.90159443 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.69603511 |
| 5 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.23562536 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18926352 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11286251 |
| 8 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.01698619 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00853787 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98296102 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97375796 |
| 12 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.89652115 |
| 13 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86248840 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 1.83675357 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.79542365 |
| 16 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.67809046 |
| 17 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66758446 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65093034 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62151715 |
| 20 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61944756 |
| 21 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.59993750 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.56467547 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.56335454 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.55303185 |
| 25 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.53359298 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53209096 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52861018 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50402437 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50389707 |
| 30 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.50038051 |
| 31 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.43295464 |
| 32 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41692817 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39290653 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.39094666 |
| 35 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.38941685 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38248413 |
| 37 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.38105552 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36999096 |
| 39 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34948499 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32829109 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32229091 |
| 42 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.31966363 |
| 43 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.31733748 |
| 44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.30109379 |
| 45 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.30078587 |
| 46 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.29842760 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29341913 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27011918 |
| 49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26448616 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.26420799 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25829433 |
| 52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25813625 |
| 53 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.25477803 |
| 54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25124352 |
| 55 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.24921841 |
| 56 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24847049 |
| 57 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.23943853 |
| 58 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22568423 |
| 59 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.22478933 |
| 60 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22379753 |
| 61 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20842617 |
| 62 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.20010612 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19360468 |
| 64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.19288973 |
| 65 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19280904 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16963922 |
| 67 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16609276 |
| 68 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.16541032 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.16044266 |
| 70 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15467030 |
| 71 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15326540 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15296070 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13585336 |
| 74 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.12866504 |
| 75 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.12755116 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12599321 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11156362 |
| 78 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10370831 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09986722 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09823701 |
| 81 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.09705294 |
| 82 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.09334966 |
| 83 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09114777 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08865415 |
| 85 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08497971 |
| 86 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08284301 |
| 87 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08246534 |
| 88 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.07952521 |
| 89 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07886644 |
| 90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07530342 |
| 91 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.07401533 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06930427 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06930427 |
| 94 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06377796 |
| 95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05845212 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05764186 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05665025 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04693505 |
| 99 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04648058 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04447420 |
| 101 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04406253 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03898670 |
| 103 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03791832 |
| 104 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03739610 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03284337 |
| 106 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03197410 |
| 107 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.03017590 |
| 108 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.03017590 |
| 109 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.02854964 |
| 110 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.02548653 |
| 111 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02192762 |
| 112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02037693 |
| 113 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01996305 |
| 114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01642882 |
| 115 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01446375 |
| 116 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01386609 |
| 117 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.00966746 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99675056 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97443893 |
| 120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97404908 |
| 121 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97402603 |
| 122 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97305085 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97224335 |
| 124 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96136660 |
| 125 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96100433 |
| 126 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95790475 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95239468 |
| 128 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94183529 |
| 129 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93917933 |
| 130 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.93340411 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93240239 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91958214 |
| 133 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.91624919 |
| 134 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91543236 |
| 135 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.90934549 |
| 136 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.90369733 |
| 137 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88400313 |
| 138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88115278 |
| 139 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87357592 |
| 140 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.87272499 |
| 141 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87208080 |
| 142 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.86669043 |
| 143 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86601169 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85983421 |
| 145 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.85965334 |
| 146 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85778517 |
| 147 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84813413 |
| 148 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84778478 |
| 149 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.84105279 |
| 150 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83924074 |
| 151 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.83416015 |
| 152 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82997280 |
| 153 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82997280 |
| 154 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82888574 |
| 155 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.82233687 |
| 156 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.81841832 |
| 157 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.81477673 |
| 158 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81032587 |
| 159 | NFYB_21822215_ChIP-Seq_K562_Human | 0.80626874 |
| 160 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79742725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 4.28555447 |
| 2 | MP0000920_abnormal_myelination | 3.42761553 |
| 3 | MP0008775_abnormal_heart_ventricle | 2.89962601 |
| 4 | MP0005360_urolithiasis | 2.88620220 |
| 5 | MP0003950_abnormal_plasma_membrane | 2.84757180 |
| 6 | MP0004043_abnormal_pH_regulation | 2.68036899 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.54075568 |
| 8 | MP0003329_amyloid_beta_deposits | 2.51210992 |
| 9 | MP0003195_calcinosis | 2.44134575 |
| 10 | MP0003690_abnormal_glial_cell | 2.39661828 |
| 11 | MP0004270_analgesia | 2.38599721 |
| 12 | MP0004885_abnormal_endolymph | 2.38292680 |
| 13 | MP0003890_abnormal_embryonic-extraembry | 2.36336401 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.25050290 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.10132095 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.09663630 |
| 17 | MP0010630_abnormal_cardiac_muscle | 2.09087585 |
| 18 | MP0004510_myositis | 2.06643862 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.05982671 |
| 20 | MP0001661_extended_life_span | 2.02469459 |
| 21 | MP0004147_increased_porphyrin_level | 1.94594936 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.93833686 |
| 23 | MP0002009_preneoplasia | 1.87906850 |
| 24 | MP0005332_abnormal_amino_acid | 1.86647702 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.85314932 |
| 26 | MP0005623_abnormal_meninges_morphology | 1.84361459 |
| 27 | MP0004484_altered_response_of | 1.82809496 |
| 28 | MP0005451_abnormal_body_composition | 1.82772250 |
| 29 | MP0000747_muscle_weakness | 1.82408660 |
| 30 | MP0004085_abnormal_heartbeat | 1.74457258 |
| 31 | MP0002127_abnormal_cardiovascular_syste | 1.74070066 |
| 32 | MP0005365_abnormal_bile_salt | 1.71551568 |
| 33 | MP0004130_abnormal_muscle_cell | 1.64764716 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.61717661 |
| 35 | MP0001485_abnormal_pinna_reflex | 1.61398407 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.60848326 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.60848326 |
| 38 | MP0003634_abnormal_glial_cell | 1.59822183 |
| 39 | MP0010678_abnormal_skin_adnexa | 1.58408188 |
| 40 | MP0000751_myopathy | 1.57650598 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.56842207 |
| 42 | MP0000462_abnormal_digestive_system | 1.56169658 |
| 43 | MP0005666_abnormal_adipose_tissue | 1.55861829 |
| 44 | MP0003698_abnormal_male_reproductive | 1.50537171 |
| 45 | MP0003567_abnormal_fetal_cardiomyocyte | 1.49815055 |
| 46 | MP0004742_abnormal_vestibular_system | 1.48815894 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.46318549 |
| 48 | MP0008057_abnormal_DNA_replication | 1.45532058 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.41644085 |
| 50 | MP0003984_embryonic_growth_retardation | 1.39824891 |
| 51 | MP0002088_abnormal_embryonic_growth/wei | 1.39033817 |
| 52 | MP0003941_abnormal_skin_development | 1.34551903 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.32111117 |
| 54 | MP0000604_amyloidosis | 1.30760103 |
| 55 | MP0003045_fibrosis | 1.30611893 |
| 56 | MP0000266_abnormal_heart_morphology | 1.30065085 |
| 57 | MP0001879_abnormal_lymphatic_vessel | 1.29053768 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.28591878 |
| 59 | MP0000778_abnormal_nervous_system | 1.26809654 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.25317586 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.23007017 |
| 62 | MP0003828_pulmonary_edema | 1.21965305 |
| 63 | MP0001672_abnormal_embryogenesis/_devel | 1.19196953 |
| 64 | MP0005380_embryogenesis_phenotype | 1.19196953 |
| 65 | MP0000383_abnormal_hair_follicle | 1.15940400 |
| 66 | MP0001440_abnormal_grooming_behavior | 1.15540443 |
| 67 | MP0002229_neurodegeneration | 1.14970193 |
| 68 | MP0009046_muscle_twitch | 1.14483587 |
| 69 | MP0003136_yellow_coat_color | 1.14264772 |
| 70 | MP0001929_abnormal_gametogenesis | 1.13173035 |
| 71 | MP0002086_abnormal_extraembryonic_tissu | 1.12559353 |
| 72 | MP0009384_cardiac_valve_regurgitation | 1.11189973 |
| 73 | MP0003632_abnormal_nervous_system | 1.10764232 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.10542759 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.10209262 |
| 76 | MP0005369_muscle_phenotype | 1.08750808 |
| 77 | MP0003252_abnormal_bile_duct | 1.08203956 |
| 78 | MP0001486_abnormal_startle_reflex | 1.06775491 |
| 79 | MP0002925_abnormal_cardiovascular_devel | 1.05149594 |
| 80 | MP0005330_cardiomyopathy | 1.05081029 |
| 81 | MP0003880_abnormal_central_pattern | 1.02423622 |
| 82 | MP0005375_adipose_tissue_phenotype | 1.02086346 |
| 83 | MP0004272_abnormal_basement_membrane | 1.01312318 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 1.00359269 |
| 85 | MP0001784_abnormal_fluid_regulation | 0.99803263 |
| 86 | MP0001299_abnormal_eye_distance/ | 0.99730385 |
| 87 | MP0000537_abnormal_urethra_morphology | 0.99563920 |
| 88 | MP0005377_hearing/vestibular/ear_phenot | 0.98996889 |
| 89 | MP0003878_abnormal_ear_physiology | 0.98996889 |
| 90 | MP0004084_abnormal_cardiac_muscle | 0.98652000 |
| 91 | MP0004087_abnormal_muscle_fiber | 0.98641844 |
| 92 | MP0005620_abnormal_muscle_contractility | 0.97973964 |
| 93 | MP0000749_muscle_degeneration | 0.97942127 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.97686575 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.97558089 |
| 96 | MP0005409_darkened_coat_color | 0.96157878 |
| 97 | MP0001666_abnormal_nutrient_absorption | 0.95708060 |
| 98 | MP0002128_abnormal_blood_circulation | 0.95288745 |
| 99 | MP0002272_abnormal_nervous_system | 0.95078836 |
| 100 | MP0009840_abnormal_foam_cell | 0.94319475 |
| 101 | MP0004233_abnormal_muscle_weight | 0.94269323 |
| 102 | MP0010329_abnormal_lipoprotein_level | 0.92467801 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.91917008 |
| 104 | MP0002734_abnormal_mechanical_nocicepti | 0.91910486 |
| 105 | MP0009643_abnormal_urine_homeostasis | 0.88841002 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.88781204 |
| 107 | MP0005165_increased_susceptibility_to | 0.88742162 |
| 108 | MP0001756_abnormal_urination | 0.88469740 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.88331581 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.88331581 |
| 111 | MP0005083_abnormal_biliary_tract | 0.88177570 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88049600 |
| 113 | MP0001529_abnormal_vocalization | 0.87693214 |
| 114 | MP0002971_abnormal_brown_adipose | 0.87544143 |
| 115 | MP0009703_decreased_birth_body | 0.86023630 |
| 116 | MP0002269_muscular_atrophy | 0.85949091 |
| 117 | MP0005187_abnormal_penis_morphology | 0.85909519 |
| 118 | MP0000759_abnormal_skeletal_muscle | 0.85849328 |
| 119 | MP0006138_congestive_heart_failure | 0.85683869 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.85208319 |
| 121 | MP0003937_abnormal_limbs/digits/tail_de | 0.84951237 |
| 122 | MP0002161_abnormal_fertility/fecundity | 0.84399516 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.83970235 |
| 124 | MP0001697_abnormal_embryo_size | 0.83684291 |
| 125 | MP0002064_seizures | 0.83132473 |
| 126 | MP0001905_abnormal_dopamine_level | 0.82238304 |
| 127 | MP0002108_abnormal_muscle_morphology | 0.81965638 |
| 128 | MP0008004_abnormal_stomach_pH | 0.81935596 |
| 129 | MP0005636_abnormal_mineral_homeostasis | 0.81132150 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.81057761 |
| 131 | MP0002084_abnormal_developmental_patter | 0.80169183 |
| 132 | MP0001730_embryonic_growth_arrest | 0.79000448 |
| 133 | MP0003631_nervous_system_phenotype | 0.78766140 |
| 134 | MP0006036_abnormal_mitochondrial_physio | 0.78685192 |
| 135 | MP0002653_abnormal_ependyma_morphology | 0.78212216 |
| 136 | MP0002168_other_aberrant_phenotype | 0.76581398 |
| 137 | MP0003283_abnormal_digestive_organ | 0.76340296 |
| 138 | MP0004134_abnormal_chest_morphology | 0.75767138 |
| 139 | MP0004215_abnormal_myocardial_fiber | 0.75717945 |
| 140 | MP0003646_muscle_fatigue | 0.75616444 |
| 141 | MP0003137_abnormal_impulse_conducting | 0.75446956 |
| 142 | MP0002166_altered_tumor_susceptibility | 0.74535236 |
| 143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74177799 |
| 144 | MP0003938_abnormal_ear_development | 0.73362111 |
| 145 | MP0000955_abnormal_spinal_cord | 0.73044855 |
| 146 | MP0004859_abnormal_synaptic_plasticity | 0.72767153 |
| 147 | MP0003935_abnormal_craniofacial_develop | 0.72318855 |
| 148 | MP0002066_abnormal_motor_capabilities/c | 0.72032927 |
| 149 | MP0005248_abnormal_Harderian_gland | 0.71779369 |
| 150 | MP0009780_abnormal_chondrocyte_physiolo | 0.71703060 |
| 151 | MP0003705_abnormal_hypodermis_morpholog | 0.71030741 |
| 152 | MP0002106_abnormal_muscle_physiology | 0.69026527 |
| 153 | MP0002080_prenatal_lethality | 0.67593749 |
| 154 | MP0001614_abnormal_blood_vessel | 0.66108747 |
| 155 | MP0003385_abnormal_body_wall | 0.62835342 |
| 156 | MP0005670_abnormal_white_adipose | 0.61692557 |
| 157 | MP0008961_abnormal_basal_metabolism | 0.59741041 |
| 158 | MP0000428_abnormal_craniofacial_morphol | 0.59587433 |
| 159 | MP0003943_abnormal_hepatobiliary_system | 0.58651412 |
| 160 | MP0002877_abnormal_melanocyte_morpholog | 0.57613052 |
| 161 | MP0010307_abnormal_tumor_latency | 0.54578242 |
| 162 | MP0003453_abnormal_keratinocyte_physiol | 0.53742293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Poikilocytosis (HP:0004447) | 6.87837671 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.50047566 |
| 3 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.07989928 |
| 4 | Bundle branch block (HP:0011710) | 4.94286292 |
| 5 | Sudden death (HP:0001699) | 4.91951061 |
| 6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.84033147 |
| 7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.84033147 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 4.68250360 |
| 9 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.67579077 |
| 10 | Absent/shortened dynein arms (HP:0200106) | 4.43891222 |
| 11 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.43891222 |
| 12 | Reticulocytosis (HP:0001923) | 4.42080238 |
| 13 | Neurofibrillary tangles (HP:0002185) | 4.38994584 |
| 14 | Acanthocytosis (HP:0001927) | 4.38073816 |
| 15 | Abnormality of the corticospinal tract (HP:0002492) | 3.99034563 |
| 16 | Abnormal ciliary motility (HP:0012262) | 3.92030551 |
| 17 | Rhinitis (HP:0012384) | 3.74029874 |
| 18 | Syncope (HP:0001279) | 3.68477966 |
| 19 | Ventricular tachycardia (HP:0004756) | 3.67658102 |
| 20 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.64868508 |
| 21 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.64868508 |
| 22 | Metabolic alkalosis (HP:0200114) | 3.63784354 |
| 23 | Sensory axonal neuropathy (HP:0003390) | 3.60081824 |
| 24 | Abnormality of the calf musculature (HP:0001430) | 3.51799466 |
| 25 | Hypokalemic alkalosis (HP:0001949) | 3.51726928 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 3.50784426 |
| 27 | Increased circulating renin level (HP:0000848) | 3.48756283 |
| 28 | Muscle fiber splitting (HP:0003555) | 3.48265074 |
| 29 | Diaphragmatic weakness (HP:0009113) | 3.39423785 |
| 30 | Termporal pattern (HP:0011008) | 3.39423502 |
| 31 | Insidious onset (HP:0003587) | 3.39423502 |
| 32 | Polycythemia (HP:0001901) | 3.24540195 |
| 33 | Subaortic stenosis (HP:0001682) | 3.21080603 |
| 34 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.21080603 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 3.13540167 |
| 36 | Atrial fibrillation (HP:0005110) | 3.11561162 |
| 37 | Heart block (HP:0012722) | 3.10127539 |
| 38 | Primary atrial arrhythmia (HP:0001692) | 3.03950986 |
| 39 | Abnormal gallbladder morphology (HP:0012437) | 2.97643883 |
| 40 | Cholelithiasis (HP:0001081) | 2.96244228 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 2.94019705 |
| 42 | Congenital malformation of the right heart (HP:0011723) | 2.93279389 |
| 43 | Double outlet right ventricle (HP:0001719) | 2.93279389 |
| 44 | Hypomagnesemia (HP:0002917) | 2.91293568 |
| 45 | Chronic bronchitis (HP:0004469) | 2.87682016 |
| 46 | Microcytic anemia (HP:0001935) | 2.86169656 |
| 47 | Papillary thyroid carcinoma (HP:0002895) | 2.82965994 |
| 48 | Supraventricular arrhythmia (HP:0005115) | 2.82724263 |
| 49 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.80793302 |
| 50 | Abnormality of glycine metabolism (HP:0010895) | 2.80793302 |
| 51 | Supraventricular tachycardia (HP:0004755) | 2.80131285 |
| 52 | Gout (HP:0001997) | 2.77821759 |
| 53 | Lipoatrophy (HP:0100578) | 2.72138226 |
| 54 | Dysmetric saccades (HP:0000641) | 2.65251460 |
| 55 | Abnormality of chloride homeostasis (HP:0011422) | 2.64651370 |
| 56 | Polyuria (HP:0000103) | 2.63327443 |
| 57 | Polydipsia (HP:0001959) | 2.61465331 |
| 58 | Abnormal drinking behavior (HP:0030082) | 2.61465331 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.61086828 |
| 60 | Hyperglycinuria (HP:0003108) | 2.60192829 |
| 61 | Abnormal urine output (HP:0012590) | 2.59709908 |
| 62 | Ventricular arrhythmia (HP:0004308) | 2.58654296 |
| 63 | Exercise-induced myalgia (HP:0003738) | 2.55774372 |
| 64 | Abnormal hemoglobin (HP:0011902) | 2.54294747 |
| 65 | Hyperglycinemia (HP:0002154) | 2.53888456 |
| 66 | Intention tremor (HP:0002080) | 2.50221669 |
| 67 | Spastic gait (HP:0002064) | 2.50088289 |
| 68 | Atrioventricular block (HP:0001678) | 2.49941203 |
| 69 | Paralysis (HP:0003470) | 2.49041989 |
| 70 | Ventricular fibrillation (HP:0001663) | 2.47959368 |
| 71 | Abnormality of the fingertips (HP:0001211) | 2.45486189 |
| 72 | Difficulty running (HP:0009046) | 2.44581512 |
| 73 | Abnormality of renal excretion (HP:0011036) | 2.41233105 |
| 74 | Dilated cardiomyopathy (HP:0001644) | 2.40061456 |
| 75 | Arterial tortuosity (HP:0005116) | 2.39061575 |
| 76 | Ankyloglossia (HP:0010296) | 2.38764523 |
| 77 | Intrahepatic cholestasis (HP:0001406) | 2.38448958 |
| 78 | Palpitations (HP:0001962) | 2.32317055 |
| 79 | Ileus (HP:0002595) | 2.28540148 |
| 80 | Deep venous thrombosis (HP:0002625) | 2.27659517 |
| 81 | Spastic tetraparesis (HP:0001285) | 2.27463178 |
| 82 | Hyperbilirubinemia (HP:0002904) | 2.26331987 |
| 83 | Supranuclear gaze palsy (HP:0000605) | 2.26012564 |
| 84 | Hyperlipoproteinemia (HP:0010980) | 2.25761249 |
| 85 | Peripheral hypomyelination (HP:0007182) | 2.24562796 |
| 86 | Onion bulb formation (HP:0003383) | 2.24485294 |
| 87 | Akinesia (HP:0002304) | 2.23945254 |
| 88 | Abnormality of sodium homeostasis (HP:0010931) | 2.23505183 |
| 89 | Renal salt wasting (HP:0000127) | 2.22582069 |
| 90 | Visceral angiomatosis (HP:0100761) | 2.21933150 |
| 91 | Spastic paraparesis (HP:0002313) | 2.21920212 |
| 92 | Parakeratosis (HP:0001036) | 2.21412812 |
| 93 | Prolonged QT interval (HP:0001657) | 2.19926148 |
| 94 | Abnormality of reticulocytes (HP:0004312) | 2.17326439 |
| 95 | Abnormality of glycolysis (HP:0004366) | 2.16941341 |
| 96 | Increased serum pyruvate (HP:0003542) | 2.16941341 |
| 97 | Infertility (HP:0000789) | 2.14944625 |
| 98 | Toxemia of pregnancy (HP:0100603) | 2.14472907 |
| 99 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.13087710 |
| 100 | EMG: neuropathic changes (HP:0003445) | 2.12568107 |
| 101 | Increased purine levels (HP:0004368) | 2.12546208 |
| 102 | Hyperuricemia (HP:0002149) | 2.12546208 |
| 103 | EMG: myopathic abnormalities (HP:0003458) | 2.12182937 |
| 104 | Truncus arteriosus (HP:0001660) | 2.10960810 |
| 105 | Hemangiomatosis (HP:0007461) | 2.10726466 |
| 106 | Hyponatremia (HP:0002902) | 2.09593060 |
| 107 | Abnormality of magnesium homeostasis (HP:0004921) | 2.07830545 |
| 108 | Cerebral hemorrhage (HP:0001342) | 2.07720973 |
| 109 | Biliary tract neoplasm (HP:0100574) | 2.07186451 |
| 110 | Bell-shaped thorax (HP:0001591) | 2.05542945 |
| 111 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.05458132 |
| 112 | Thyroid carcinoma (HP:0002890) | 2.03893597 |
| 113 | Exercise-induced muscle cramps (HP:0003710) | 2.03747590 |
| 114 | Ketosis (HP:0001946) | 2.02868963 |
| 115 | Xanthomatosis (HP:0000991) | 2.01901939 |
| 116 | Vascular tortuosity (HP:0004948) | 2.01226916 |
| 117 | Abnormality of the gallbladder (HP:0005264) | 2.00876028 |
| 118 | Germ cell neoplasia (HP:0100728) | 2.00534183 |
| 119 | Abnormal biliary tract morphology (HP:0012440) | 1.98383711 |
| 120 | Hip contracture (HP:0003273) | 1.97718064 |
| 121 | Alkalosis (HP:0001948) | 1.97375994 |
| 122 | Overgrowth (HP:0001548) | 1.96486455 |
| 123 | Asymmetric septal hypertrophy (HP:0001670) | 1.95250799 |
| 124 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.92248954 |
| 125 | Male infertility (HP:0003251) | 1.91793995 |
| 126 | Round ear (HP:0100830) | 1.90645035 |
| 127 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.89975367 |
| 128 | Hyperactive renin-angiotensin system (HP:0000841) | 1.89372524 |
| 129 | Hyperaldosteronism (HP:0000859) | 1.88683288 |
| 130 | Testicular neoplasm (HP:0010788) | 1.87811070 |
| 131 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.87476446 |
| 132 | Hyperglycemia (HP:0003074) | 1.86351656 |
| 133 | Cholecystitis (HP:0001082) | 1.85885756 |
| 134 | Abnormal gallbladder physiology (HP:0012438) | 1.85885756 |
| 135 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.85602133 |
| 136 | Hypoglycemic seizures (HP:0002173) | 1.85535132 |
| 137 | Pheochromocytoma (HP:0002666) | 1.85183445 |
| 138 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.84807684 |
| 139 | Coronal craniosynostosis (HP:0004440) | 1.83151068 |
| 140 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.81148123 |
| 141 | Transposition of the great arteries (HP:0001669) | 1.81148123 |
| 142 | Abnormal connection of the cardiac segments (HP:0011545) | 1.81148123 |
| 143 | Dysmetria (HP:0001310) | 1.80683037 |
| 144 | Lower limb muscle weakness (HP:0007340) | 1.80051944 |
| 145 | Abnormal auditory evoked potentials (HP:0006958) | 1.78688020 |
| 146 | Stridor (HP:0010307) | 1.78686091 |
| 147 | Neoplasm of the small intestine (HP:0100833) | 1.78427376 |
| 148 | Gowers sign (HP:0003391) | 1.77201907 |
| 149 | Macroorchidism (HP:0000053) | 1.75787220 |
| 150 | Nemaline bodies (HP:0003798) | 1.74941727 |
| 151 | Decreased circulating renin level (HP:0003351) | 1.74029141 |
| 152 | Urinary urgency (HP:0000012) | 1.73593770 |
| 153 | Autoamputation (HP:0001218) | 1.72794900 |
| 154 | Tetraparesis (HP:0002273) | 1.72588508 |
| 155 | Osteomalacia (HP:0002749) | 1.71517588 |
| 156 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.71348933 |
| 157 | Abnormal pancreas size (HP:0012094) | 1.71334379 |
| 158 | Muscle fiber inclusion bodies (HP:0100299) | 1.70724749 |
| 159 | Adrenal overactivity (HP:0002717) | 1.70328395 |
| 160 | Acute myeloid leukemia (HP:0004808) | 1.70078443 |
| 161 | Abnormality of renin-angiotensin system (HP:0000847) | 1.69325863 |
| 162 | Back pain (HP:0003418) | 1.69320893 |
| 163 | Tubulointerstitial fibrosis (HP:0005576) | 1.66512792 |
| 164 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.66372808 |
| 165 | Gastrointestinal carcinoma (HP:0002672) | 1.66372808 |
| 166 | Limited hip movement (HP:0008800) | 1.65629005 |
| 167 | Abnormality of potassium homeostasis (HP:0011042) | 1.65252270 |
| 168 | Hypoglycemic coma (HP:0001325) | 1.64835987 |
| 169 | Hypokalemia (HP:0002900) | 1.63078742 |
| 170 | Skin pits (HP:0100276) | 1.61598517 |
| 171 | Megalencephaly (HP:0001355) | 1.60891585 |
| 172 | Anteriorly placed anus (HP:0001545) | 1.60801107 |
| 173 | Curly hair (HP:0002212) | 1.60308931 |
| 174 | Abnormal EKG (HP:0003115) | 1.60175114 |
| 175 | Hyperammonemia (HP:0001987) | 1.59521527 |
| 176 | Ankle clonus (HP:0011448) | 1.59477183 |
| 177 | Increased variability in muscle fiber diameter (HP:0003557) | 1.59090449 |
| 178 | Hyperkalemia (HP:0002153) | 1.56256503 |
| 179 | Myoglobinuria (HP:0002913) | 1.55994969 |
| 180 | Infantile muscular hypotonia (HP:0008947) | 1.54486993 |
| 181 | Calf muscle hypertrophy (HP:0008981) | 1.54360594 |
| 182 | Premature rupture of membranes (HP:0001788) | 1.54184979 |
| 183 | Leukodystrophy (HP:0002415) | 1.54174474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.13999789 |
| 2 | OXSR1 | 4.84341141 |
| 3 | EIF2AK1 | 4.65632992 |
| 4 | WNK4 | 4.17799629 |
| 5 | PDK3 | 3.39973345 |
| 6 | PDK4 | 3.39973345 |
| 7 | AKT3 | 2.94156221 |
| 8 | PKN2 | 2.92121934 |
| 9 | PNCK | 2.91910231 |
| 10 | ICK | 2.86628486 |
| 11 | PDK2 | 2.53262649 |
| 12 | EPHB1 | 2.29164629 |
| 13 | WNK1 | 2.25730578 |
| 14 | MET | 2.23272400 |
| 15 | EEF2K | 2.08642709 |
| 16 | FGFR2 | 2.01199867 |
| 17 | SGK2 | 1.96582445 |
| 18 | STK38L | 1.87699552 |
| 19 | WNK3 | 1.84410074 |
| 20 | BRSK2 | 1.79704620 |
| 21 | PRPF4B | 1.79034574 |
| 22 | TIE1 | 1.77085978 |
| 23 | STK4 | 1.75096761 |
| 24 | SGK3 | 1.73122145 |
| 25 | MARK1 | 1.72816782 |
| 26 | PAK6 | 1.65664207 |
| 27 | BCR | 1.63630982 |
| 28 | CDK19 | 1.60650012 |
| 29 | PKN1 | 1.56644737 |
| 30 | STK24 | 1.55597581 |
| 31 | MYLK | 1.53485437 |
| 32 | PHKG2 | 1.43929934 |
| 33 | PHKG1 | 1.43929934 |
| 34 | NTRK3 | 1.40317726 |
| 35 | SCYL2 | 1.35565373 |
| 36 | PAK3 | 1.33147407 |
| 37 | FGFR3 | 1.28214290 |
| 38 | LIMK1 | 1.26330722 |
| 39 | PRKD3 | 1.22748753 |
| 40 | NTRK1 | 1.18021671 |
| 41 | CSNK1A1L | 1.14950855 |
| 42 | CSNK1G3 | 1.14244503 |
| 43 | CAMK1D | 1.10723998 |
| 44 | TYRO3 | 1.10654731 |
| 45 | MAPK15 | 1.07433073 |
| 46 | BRD4 | 1.06508586 |
| 47 | CDK12 | 1.06385525 |
| 48 | CSNK1G1 | 1.04622980 |
| 49 | MKNK2 | 1.04215104 |
| 50 | CSNK1G2 | 1.03028771 |
| 51 | FLT3 | 0.99270913 |
| 52 | MAP3K9 | 0.97638367 |
| 53 | PDPK1 | 0.97514792 |
| 54 | BMX | 0.97177836 |
| 55 | MAP2K1 | 0.95991559 |
| 56 | ROCK2 | 0.95623988 |
| 57 | NEK9 | 0.92493907 |
| 58 | BCKDK | 0.92117353 |
| 59 | MAP3K10 | 0.91716828 |
| 60 | LATS1 | 0.91627329 |
| 61 | NEK6 | 0.90626537 |
| 62 | NLK | 0.89824902 |
| 63 | KSR1 | 0.88777723 |
| 64 | MAP3K7 | 0.87481387 |
| 65 | SGK1 | 0.87162540 |
| 66 | CAMK1G | 0.86040123 |
| 67 | PTK2B | 0.85924328 |
| 68 | KSR2 | 0.85848532 |
| 69 | ACVR1B | 0.85476444 |
| 70 | PIK3CA | 0.84993401 |
| 71 | EIF2AK3 | 0.84773621 |
| 72 | RET | 0.84727809 |
| 73 | DDR2 | 0.84281032 |
| 74 | TESK2 | 0.83722880 |
| 75 | MAPK12 | 0.80796342 |
| 76 | TTN | 0.79951662 |
| 77 | LATS2 | 0.79302827 |
| 78 | CAMK2D | 0.77458537 |
| 79 | MST4 | 0.76916691 |
| 80 | TESK1 | 0.76877458 |
| 81 | CLK1 | 0.75516303 |
| 82 | ERBB4 | 0.74822689 |
| 83 | STK11 | 0.74327734 |
| 84 | PBK | 0.73401181 |
| 85 | OBSCN | 0.72798349 |
| 86 | HIPK2 | 0.71603470 |
| 87 | SGK494 | 0.71415368 |
| 88 | SGK223 | 0.71415368 |
| 89 | MST1R | 0.71123088 |
| 90 | CAMK2B | 0.69930169 |
| 91 | GSK3A | 0.69421650 |
| 92 | CDK14 | 0.68882038 |
| 93 | CAMK2G | 0.68739746 |
| 94 | FER | 0.68489353 |
| 95 | DMPK | 0.68022916 |
| 96 | EPHB2 | 0.67888824 |
| 97 | STK38 | 0.67376597 |
| 98 | PINK1 | 0.66211331 |
| 99 | DYRK2 | 0.66046554 |
| 100 | PDK1 | 0.65772144 |
| 101 | CAMK4 | 0.64740329 |
| 102 | FGR | 0.62610694 |
| 103 | BMPR1B | 0.60697567 |
| 104 | MAP2K2 | 0.60223605 |
| 105 | UHMK1 | 0.60097160 |
| 106 | TTK | 0.58528316 |
| 107 | CDK15 | 0.58477427 |
| 108 | MAP3K1 | 0.58227233 |
| 109 | TRIB3 | 0.58066771 |
| 110 | STK3 | 0.57543387 |
| 111 | CDK5 | 0.56052605 |
| 112 | PAK2 | 0.55590828 |
| 113 | MAPKAPK5 | 0.55378500 |
| 114 | EPHA4 | 0.55270723 |
| 115 | RIPK1 | 0.54594286 |
| 116 | EPHA2 | 0.54140696 |
| 117 | PLK2 | 0.53257326 |
| 118 | PIM1 | 0.51911917 |
| 119 | PRKAA1 | 0.51326533 |
| 120 | MAPK10 | 0.51075838 |
| 121 | CDK18 | 0.49503757 |
| 122 | PRKD1 | 0.49464305 |
| 123 | BMPR2 | 0.48991858 |
| 124 | ARAF | 0.48987188 |
| 125 | PDGFRA | 0.48250893 |
| 126 | CDK11A | 0.47899714 |
| 127 | YES1 | 0.46959208 |
| 128 | AKT2 | 0.44930072 |
| 129 | CSNK1D | 0.44578331 |
| 130 | LMTK2 | 0.44389259 |
| 131 | CAMK2A | 0.43055512 |
| 132 | MAP3K13 | 0.41775771 |
| 133 | RPS6KB2 | 0.41520737 |
| 134 | MAP3K2 | 0.41099982 |
| 135 | RAF1 | 0.40539352 |
| 136 | PRKCQ | 0.39694696 |
| 137 | MAP3K4 | 0.39670332 |
| 138 | MAPKAPK3 | 0.38646953 |
| 139 | TNIK | 0.37964934 |
| 140 | PRKACB | 0.37140566 |
| 141 | ERBB2 | 0.34007586 |
| 142 | CAMK1 | 0.33878572 |
| 143 | ERBB3 | 0.33455940 |
| 144 | PDGFRB | 0.33047591 |
| 145 | FGFR4 | 0.33014032 |
| 146 | MELK | 0.32767899 |
| 147 | MARK2 | 0.32541697 |
| 148 | MAP2K4 | 0.32294059 |
| 149 | PAK1 | 0.32054469 |
| 150 | PLK3 | 0.31713951 |
| 151 | PRKAA2 | 0.31359364 |
| 152 | FRK | 0.31300316 |
| 153 | PTK2 | 0.31189487 |
| 154 | ROCK1 | 0.30932461 |
| 155 | RPS6KA3 | 0.30215791 |
| 156 | TRPM7 | 0.28884427 |
| 157 | CSNK1E | 0.28598989 |
| 158 | ABL2 | 0.28138769 |
| 159 | PRKG1 | 0.27305614 |
| 160 | PRKCE | 0.26502055 |
| 161 | MTOR | 0.25743361 |
| 162 | FYN | 0.25569774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.64779204 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.28965495 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.84746652 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.80748432 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.76413350 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.67624714 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.56526195 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37257235 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35273719 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.30679792 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.23399542 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21521417 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19434334 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13934624 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.13564178 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01366031 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 1.94365598 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91238035 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.87638404 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74363923 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.63301830 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.60432312 |
| 23 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.53878176 |
| 24 | Endometrial cancer_Homo sapiens_hsa05213 | 1.47059388 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.43745284 |
| 26 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.43639946 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.38858136 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36844772 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.36345561 |
| 30 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.36315321 |
| 31 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.35665660 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 1.34735485 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32820831 |
| 34 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.31890604 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30074026 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.29145774 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.27835603 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25188572 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21454521 |
| 40 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.21199908 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20864580 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.18309585 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18045990 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.17742537 |
| 45 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.17277590 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17056988 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16880179 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15379863 |
| 49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.14191829 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.13815399 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13756314 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11683528 |
| 53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11151967 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10547657 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09654601 |
| 56 | Prostate cancer_Homo sapiens_hsa05215 | 1.08002503 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07359716 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05841307 |
| 59 | Glioma_Homo sapiens_hsa05214 | 1.05563112 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05300285 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05081971 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04324933 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04307839 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 1.03166634 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01446975 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00976354 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99486954 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.98141994 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97615300 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97051700 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.96129350 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.95683107 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95427609 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94313723 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.92581744 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92468653 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90494031 |
| 78 | Axon guidance_Homo sapiens_hsa04360 | 0.90355894 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90186409 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89204629 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88738007 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88644202 |
| 83 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88395560 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87494615 |
| 85 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.86910296 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85886846 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85815464 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84662320 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.81229894 |
| 90 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80793683 |
| 91 | Melanoma_Homo sapiens_hsa05218 | 0.80543306 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79582658 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79229604 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79023969 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75948814 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75729616 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74982333 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73993663 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73563801 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72676093 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71734031 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71700455 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69514997 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.68628426 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67595884 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67434231 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66718611 |
| 108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66306151 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66248605 |
| 110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63620654 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63097238 |
| 112 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62606272 |
| 113 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62520525 |
| 114 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61959536 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61939683 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61525184 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61200663 |
| 118 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60836245 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.55642793 |
| 120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55443094 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.55380480 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55303936 |
| 123 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54406317 |
| 124 | Melanogenesis_Homo sapiens_hsa04916 | 0.52693662 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51976944 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51597759 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.51101780 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51080904 |
| 129 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48856848 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48061018 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47265050 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45974775 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45107761 |
| 134 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44669847 |
| 135 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43511502 |
| 136 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41671535 |
| 137 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41415463 |
| 138 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.39517067 |
| 139 | Endocytosis_Homo sapiens_hsa04144 | 0.38857224 |
| 140 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38448127 |
| 141 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37545446 |
| 142 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37054410 |
| 143 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36726023 |
| 144 | ABC transporters_Homo sapiens_hsa02010 | 0.36674378 |
| 145 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36265437 |
| 146 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36070908 |
| 147 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35351593 |
| 148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34197037 |
| 149 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33928180 |
| 150 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33668878 |
| 151 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.31890261 |
| 152 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29764687 |
| 153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29551558 |
| 154 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28869425 |
| 155 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28112323 |
| 156 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28048821 |
| 157 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27428333 |

